Patents by Inventor Kevin K. W. Wang

Kevin K. W. Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers of liver injury
    Patent number: 7645584
    Abstract: Novel, sensitive and specific markers for diagnostics and monitoring of liver injuries, including, but not limited to ischemic liver damage, are provided. This includes identification several enzymes of arginine/urea/nitric oxide cycle, sulfuration enzymes and spectrin breakdown related products, among others.
    Type: Grant
    Filed: March 31, 2006
    Date of Patent: January 12, 2010
    Assignees: University of Florida Research Foundation, Inc., Banyan Biomarkers
    Inventors: Stanislav I. Svetlov, Ronald L. Hayes, Kevin K. W. Wang, Monika Oli, Andrew K. Ottens
  • Real-Time Assessment of Biomarkers for Disease
    Publication number: 20080204043
    Abstract: A system and methods, thereof, monitor biomarkers from a patient suffering from neural injury in real-time. The system comprises a quartz crystal microbalance wherein a capture molecule specific for certain biomarkers is diagnostic of the type of neural injury, location of neural injury and the degree of severity of neural injury. The system, in particular, provides real-time continuous monitoring of a patient.
    Type: Application
    Filed: October 27, 2005
    Publication date: August 28, 2008
    Applicant: University of Florida Research Foundation, Inc.
    Inventors: Kevin K.W. Wang, Andrew K. Ottens
  • Detection of spectrin and spectrin proteolytic cleavage products in assessing nerve cell damage
    Patent number: 7291710
    Abstract: Methods for detecting a cell damage relate to the discovery that proteases are selectively activated in subjects suffering from nervous system damage compared to samples from healthy subjects. Breakdown products reflecting activation of proteases that degrade spectrin are produced. A cell injury is detected by providing a biological sample derived from the subject; detecting in the sample the presence of these breakdown products generated by multiple proteases, and correlating the presence of these breakdown products with the presence or type of cell damage.
    Type: Grant
    Filed: September 11, 2003
    Date of Patent: November 6, 2007
    Assignee: University of Florida Research Foundation, Inc.
    Inventors: Ronald L. Hayes, Kevin K. W. Wang, Brian R. Pike